aod9604 fat loss efficacy side effects AOD-9604 (10mg vials) Understanding AOD 9604: The Science

NNMT inhibition as a therapeutic strategy has been explored in industry pharmaceutical pipelines (including a Pfizer program for non-alcoholic fatty liver disease that was reportedly discontinued in early clinical development), but no NNMT inhibitor has reached regulatory approval to date

This modified sequence was designed to retain the fat-burning properties of HGH without the anabolic or insulin-like growth factor 1 (IGF-1) stimulating effects

Compound quality affects experimental data so third-party verification is essential for meaningful scientific research

Lower NAD+ means reduced sirtuin activity (SIRT1, SIRT3), which further impairs mitochondrial function and fatty acid oxidation in fat cells

Molecular Weight: ~286.11 g/mol iodide